763 lines
34 KiB
HTML
763 lines
34 KiB
HTML
|
||
<!DOCTYPE html>
|
||
<html lang="zh-CN">
|
||
<head>
|
||
<meta charset="utf-8" />
|
||
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
|
||
<title>创新药行业洞察报告</title>
|
||
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700;800&display=swap" rel="stylesheet" />
|
||
<link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
|
||
<link href="https://cdn.jsdelivr.net/npm/daisyui@5/dist/full.min.css" rel="stylesheet">
|
||
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
|
||
<style>
|
||
body {
|
||
font-family: 'Inter', sans-serif;
|
||
background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
|
||
min-height: 100vh;
|
||
}
|
||
.section-card {
|
||
backdrop-filter: blur(10px);
|
||
background: rgba(255, 255, 255, 0.85);
|
||
box-shadow: 0 8px 32px 0 rgba(31, 38, 135, 0.15);
|
||
border: 1px solid rgba(255, 255, 255, 0.18);
|
||
}
|
||
.timeline-item {
|
||
position: relative;
|
||
padding-left: 30px;
|
||
}
|
||
.timeline-item:before {
|
||
content: "";
|
||
position: absolute;
|
||
left: 0;
|
||
top: 8px;
|
||
width: 12px;
|
||
height: 12px;
|
||
border-radius: 50%;
|
||
background: #3b82f6;
|
||
}
|
||
.timeline-item:after {
|
||
content: "";
|
||
position: absolute;
|
||
left: 5px;
|
||
top: 20px;
|
||
width: 2px;
|
||
height: calc(100% - 12px);
|
||
background: #e5e7eb;
|
||
}
|
||
.timeline-item:last-child:after {
|
||
display: none;
|
||
}
|
||
.highlight {
|
||
background: linear-gradient(120deg, #a1c4fd 0%, #c2e9fb 100%);
|
||
padding: 2px 6px;
|
||
border-radius: 4px;
|
||
font-weight: 600;
|
||
}
|
||
.table-container {
|
||
overflow-x: auto;
|
||
}
|
||
@media (max-width: 768px) {
|
||
.section-card {
|
||
margin-bottom: 1rem;
|
||
}
|
||
}
|
||
#particles-js {
|
||
position: fixed;
|
||
width: 100%;
|
||
height: 100%;
|
||
top: 0;
|
||
left: 0;
|
||
z-index: -1;
|
||
}
|
||
</style>
|
||
</head>
|
||
<body class="text-gray-800">
|
||
<div id="particles-js"></div>
|
||
|
||
<div class="container mx-auto px-4 py-8 max-w-7xl">
|
||
<!-- 标题部分 -->
|
||
<div class="text-center mb-12">
|
||
<h1 class="text-4xl md:text-5xl font-bold text-gray-900 mb-4">创新药行业洞察报告</h1>
|
||
<p class="text-xl text-gray-600">从"中国故事"走向"全球订单"的产业变革</p>
|
||
</div>
|
||
|
||
<!-- 概念事件时间轴 -->
|
||
<div class="section-card rounded-2xl p-6 mb-8">
|
||
<h2 class="text-2xl font-bold text-gray-900 mb-6 flex items-center">
|
||
<i class="fas fa-history text-blue-500 mr-3"></i>概念事件
|
||
</h2>
|
||
<div class="space-y-4">
|
||
<div class="timeline-item">
|
||
<h3 class="font-semibold text-lg">2015-2017：药审改革破冰</h3>
|
||
<p class="text-gray-600">44号文重新定义新药标准，加入ICH接轨国际</p>
|
||
</div>
|
||
<div class="timeline-item">
|
||
<h3 class="font-semibold text-lg">2018-2020：资本涌入期</h3>
|
||
<p class="text-gray-600">科创板/港股18A开通，2021年融资峰值<span class="highlight">551亿美元</span></p>
|
||
</div>
|
||
<div class="timeline-item">
|
||
<h3 class="font-semibold text-lg">2021-2023：政策纠偏期</h3>
|
||
<p class="text-gray-600">CDE提高同质化门槛，医保谈判降价趋稳</p>
|
||
</div>
|
||
<div class="timeline-item">
|
||
<h3 class="font-semibold text-lg">2024-2025：新质生产力转型</h3>
|
||
<ul class="list-disc list-inside text-gray-600 space-y-1">
|
||
<li>2024年7月：国务院发布《全链条支持创新药实施方案》，首次将创新药纳入"新质生产力"</li>
|
||
<li>2025年6月：医保局明确"丙类目录"对接商保，<span class="highlight">30日默示许可</span>缩短临床审批</li>
|
||
<li>2025年Q1：中国创新药License-out交易额<span class="highlight">366亿美元</span>（同比+258%），创历史新高</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 核心观点摘要 -->
|
||
<div class="section-card rounded-2xl p-6 mb-8">
|
||
<h2 class="text-2xl font-bold text-gray-900 mb-6 flex items-center">
|
||
<i class="fas fa-lightbulb text-yellow-500 mr-3"></i>核心观点摘要
|
||
</h2>
|
||
<div class="grid md:grid-cols-3 gap-6">
|
||
<div class="bg-blue-50 p-5 rounded-xl">
|
||
<h3 class="font-semibold text-lg mb-3 text-blue-800">阶段判断</h3>
|
||
<p class="text-gray-700">中国创新药已从"政策红利期"进入"全球化兑现期"，<span class="highlight">2025-2026年将是盈利拐点</span></p>
|
||
</div>
|
||
<div class="bg-green-50 p-5 rounded-xl">
|
||
<h3 class="font-semibold text-lg mb-3 text-green-800">核心驱动力</h3>
|
||
<p class="text-gray-700">政策全链条支持（医保+商保双轮驱动）+ 技术迭代（ADC/双抗/CAR-T）+ 出海License-out爆发</p>
|
||
</div>
|
||
<div class="bg-purple-50 p-5 rounded-xl">
|
||
<h3 class="font-semibold text-lg mb-3 text-purple-800">未来潜力</h3>
|
||
<p class="text-gray-700">2024年市场规模<span class="highlight">1.14万亿</span>，预计2025-2030年CAGR <span class="highlight">10%+</span>，出海峰值空间或超<span class="highlight">1000亿美元</span></p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 核心逻辑与市场认知 -->
|
||
<div class="section-card rounded-2xl p-6 mb-8">
|
||
<h2 class="text-2xl font-bold text-gray-900 mb-6 flex items-center">
|
||
<i class="fas fa-brain text-purple-500 mr-3"></i>核心逻辑与市场认知分析
|
||
</h2>
|
||
|
||
<div class="mb-6">
|
||
<h3 class="text-xl font-semibold mb-4 text-gray-800">核心驱动力</h3>
|
||
<div class="grid md:grid-cols-3 gap-4">
|
||
<div>
|
||
<h4 class="font-medium mb-2 text-blue-700">政策端</h4>
|
||
<ul class="text-sm text-gray-600 space-y-1">
|
||
<li>• 支付扩容：2025年丙类目录落地，商保覆盖创新药数量从2024年<span class="highlight">120款</span>扩至<span class="highlight">500+款</span></li>
|
||
<li>• 审评提速：临床试验审批从60日压缩至<span class="highlight">30日</span>，2024年1类创新药获批<span class="highlight">48款</span>（同比+60%）</li>
|
||
</ul>
|
||
</div>
|
||
<div>
|
||
<h4 class="font-medium mb-2 text-green-700">技术端</h4>
|
||
<ul class="text-sm text-gray-600 space-y-1">
|
||
<li>• ADC/双抗：中国占全球管线<span class="highlight">50%+</span>（如科伦SKB264授权默沙东<span class="highlight">14.1亿美元</span>）</li>
|
||
<li>• CAR-T：2024年全球交易中国占比<span class="highlight">38%</span>，实体瘤突破（如泽璟ZG006）</li>
|
||
</ul>
|
||
</div>
|
||
<div>
|
||
<h4 class="font-medium mb-2 text-purple-700">商业化端</h4>
|
||
<ul class="text-sm text-gray-600 space-y-1">
|
||
<li>• 头部企业盈利：百济神州2025年Q1首次GAAP盈利</li>
|
||
<li>• 恒瑞创新药收入占比<span class="highlight">49.6%</span>（2024年138.9亿）</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="mb-6">
|
||
<h3 class="text-xl font-semibold mb-4 text-gray-800">市场热度与情绪</h3>
|
||
<div class="bg-gray-50 p-4 rounded-lg">
|
||
<ul class="text-gray-600 space-y-2">
|
||
<li>• 研报密度：2025年6月单月<span class="highlight">15篇</span>深度报告聚焦出海（东吴、天风、海通集体唱多）</li>
|
||
<li>• 情绪指标：港股创新药ETF在关税恐慌中<span class="highlight">单日涨3.5%</span>（市场认知BD出海免疫关税）</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
|
||
<div>
|
||
<h3 class="text-xl font-semibold mb-4 text-gray-800">预期差</h3>
|
||
<div class="bg-yellow-50 p-4 rounded-lg border-l-4 border-yellow-400">
|
||
<h4 class="font-medium mb-2 text-yellow-800">市场忽略点</h4>
|
||
<ul class="text-gray-700 space-y-1">
|
||
<li>• 支付端弹性：商保对高价药（如CAR-T定价<span class="highlight">120万</span>）的支付比例或超预期（北京普惠健康保已覆盖）</li>
|
||
<li>• 技术代差：中国ADC毒素链接技术（如荣昌RC48）已领先全球，但估值未充分反映（PE仅<span class="highlight">25倍</span> vs 国际龙头<span class="highlight">50倍</span>）</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 关键催化剂 -->
|
||
<div class="section-card rounded-2xl p-6 mb-8">
|
||
<h2 class="text-2xl font-bold text-gray-900 mb-6 flex items-center">
|
||
<i class="fas fa-rocket text-red-500 mr-3"></i>关键催化剂与未来发展路径
|
||
</h2>
|
||
|
||
<div class="mb-6">
|
||
<h3 class="text-xl font-semibold mb-4 text-gray-800">近期催化剂（3-6个月）</h3>
|
||
<div class="grid md:grid-cols-3 gap-4">
|
||
<div class="bg-red-50 p-4 rounded-lg">
|
||
<div class="text-red-600 font-medium mb-2">2025年9月</div>
|
||
<p class="text-gray-700 text-sm">丙类目录首批名单公布（预计纳入<span class="highlight">50-80款</span>高价值创新药）</p>
|
||
</div>
|
||
<div class="bg-red-50 p-4 rounded-lg">
|
||
<div class="text-red-600 font-medium mb-2">2025年ASCO</div>
|
||
<p class="text-gray-700 text-sm">中国ADC/双抗数据读出（如石药SYS6010胃癌ORR <span class="highlight">50%</span>）</p>
|
||
</div>
|
||
<div class="bg-red-50 p-4 rounded-lg">
|
||
<div class="text-red-600 font-medium mb-2">2025年Q3</div>
|
||
<p class="text-gray-700 text-sm">百济神州泽布替尼美国市占率突破<span class="highlight">15%</span>（当前12.7%）</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div>
|
||
<h3 class="text-xl font-semibold mb-4 text-gray-800">长期路径</h3>
|
||
<div class="bg-gradient-to-r from-blue-50 to-purple-50 p-6 rounded-xl">
|
||
<div class="grid md:grid-cols-2 gap-6">
|
||
<div>
|
||
<h4 class="font-semibold text-blue-800 mb-2">2025-2026</h4>
|
||
<p class="text-gray-700">头部Biotech盈亏平衡（信达、康方等）</p>
|
||
</div>
|
||
<div>
|
||
<h4 class="font-semibold text-purple-800 mb-2">2027-2030</h4>
|
||
<p class="text-gray-700">中国FIC药物全球占比从<span class="highlight">30%</span>提升至<span class="highlight">50%</span>（如KRAS G12D抑制剂）</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 产业链与核心公司 -->
|
||
<div class="section-card rounded-2xl p-6 mb-8">
|
||
<h2 class="text-2xl font-bold text-gray-900 mb-6 flex items-center">
|
||
<i class="fas fa-sitemap text-indigo-500 mr-3"></i>产业链与核心公司深度剖析
|
||
</h2>
|
||
|
||
<div class="mb-6">
|
||
<h3 class="text-xl font-semibold mb-4 text-gray-800">产业链图谱</h3>
|
||
<div class="flex flex-wrap justify-center items-center gap-4 py-6">
|
||
<div class="bg-blue-100 px-6 py-3 rounded-full font-medium text-blue-800">上游：CXO</div>
|
||
<div class="text-2xl text-gray-400">→</div>
|
||
<div class="bg-green-100 px-6 py-3 rounded-full font-medium text-green-800">中游：创新药企</div>
|
||
<div class="text-2xl text-gray-400">→</div>
|
||
<div class="bg-purple-100 px-6 py-3 rounded-full font-medium text-purple-800">下游：医院/DTP药房/商保</div>
|
||
</div>
|
||
<p class="text-center text-gray-600 text-sm mt-2">代表企业：药明康德、泰格医药 → 恒瑞、百济、信达 → 医院终端</p>
|
||
</div>
|
||
|
||
<div>
|
||
<h3 class="text-xl font-semibold mb-4 text-gray-800">核心玩家对比</h3>
|
||
<div class="overflow-x-auto">
|
||
<table class="min-w-full bg-white rounded-lg overflow-hidden">
|
||
<thead class="bg-gray-100">
|
||
<tr>
|
||
<th class="px-4 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">公司</th>
|
||
<th class="px-4 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">核心逻辑</th>
|
||
<th class="px-4 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">风险点</th>
|
||
<th class="px-4 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">估值（2025E PE）</th>
|
||
</tr>
|
||
</thead>
|
||
<tbody class="divide-y divide-gray-200">
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">百济神州</td>
|
||
<td class="px-4 py-3 text-sm">泽布替尼全球放量（2025年峰值<span class="highlight">30亿美元</span>）</td>
|
||
<td class="px-4 py-3 text-sm">国际化销售费用高企</td>
|
||
<td class="px-4 py-3 text-sm font-medium"><span class="highlight">35倍</span></td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">恒瑞医药</td>
|
||
<td class="px-4 py-3 text-sm">13款创新药上市，ADC平台授权<span class="highlight">7亿美元</span></td>
|
||
<td class="px-4 py-3 text-sm">集采压制仿制药利润</td>
|
||
<td class="px-4 py-3 text-sm font-medium"><span class="highlight">28倍</span></td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">科伦博泰</td>
|
||
<td class="px-4 py-3 text-sm">SKB264授权默沙东，里程碑<span class="highlight">14.1亿美元</span></td>
|
||
<td class="px-4 py-3 text-sm">依赖单一管线</td>
|
||
<td class="px-4 py-3 text-sm font-medium"><span class="highlight">40倍</span></td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">信达生物</td>
|
||
<td class="px-4 py-3 text-sm">IBI363鳞癌数据优异（ORR <span class="highlight">36.7%</span>）</td>
|
||
<td class="px-4 py-3 text-sm">现金流缺口（2024年亏损<span class="highlight">10亿</span>）</td>
|
||
<td class="px-4 py-3 text-sm font-medium text-red-600">亏损</td>
|
||
</tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 潜在风险 -->
|
||
<div class="section-card rounded-2xl p-6 mb-8">
|
||
<h2 class="text-2xl font-bold text-gray-900 mb-6 flex items-center">
|
||
<i class="fas fa-exclamation-triangle text-orange-500 mr-3"></i>潜在风险与挑战
|
||
</h2>
|
||
<div class="grid md:grid-cols-2 gap-4">
|
||
<div class="bg-orange-50 p-4 rounded-lg">
|
||
<h3 class="font-semibold text-orange-800 mb-2">技术风险</h3>
|
||
<p class="text-gray-700 text-sm">双抗毒性管理（如康方AK104的<span class="highlight">3级CRS发生率2%</span>）</p>
|
||
</div>
|
||
<div class="bg-orange-50 p-4 rounded-lg">
|
||
<h3 class="font-semibold text-orange-800 mb-2">商业化风险</h3>
|
||
<p class="text-gray-700 text-sm">医保谈判降价超预期（2024年平均降幅<span class="highlight">63%</span>）</p>
|
||
</div>
|
||
<div class="bg-orange-50 p-4 rounded-lg">
|
||
<h3 class="font-semibold text-orange-800 mb-2">政策风险</h3>
|
||
<p class="text-gray-700 text-sm">美国拟对进口药品加关税（但BD出海<span class="highlight">免疫关税</span>）</p>
|
||
</div>
|
||
<div class="bg-orange-50 p-4 rounded-lg">
|
||
<h3 class="font-semibold text-orange-800 mb-2">信息矛盾</h3>
|
||
<p class="text-gray-700 text-sm">路演称"中国FIC占比30%"，但2024年全球FIC仅<span class="highlight">11款</span>来自中国，需验证统计口径</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 综合结论 -->
|
||
<div class="section-card rounded-2xl p-6 mb-8 bg-gradient-to-br from-blue-50 to-indigo-50">
|
||
<h2 class="text-2xl font-bold text-gray-900 mb-6 flex items-center">
|
||
<i class="fas fa-chart-line text-green-500 mr-3"></i>综合结论与投资启示
|
||
</h2>
|
||
|
||
<div class="mb-6">
|
||
<h3 class="text-xl font-semibold mb-3 text-gray-800">阶段判断</h3>
|
||
<p class="text-gray-700">从主题炒作（2021年PE <span class="highlight">150倍</span>）进入基本面驱动（2025年PE <span class="highlight">25-40倍</span>）</p>
|
||
</div>
|
||
|
||
<div class="mb-6">
|
||
<h3 class="text-xl font-semibold mb-3 text-gray-800">投资方向</h3>
|
||
<div class="grid md:grid-cols-2 gap-4">
|
||
<div class="bg-white p-4 rounded-lg shadow-sm">
|
||
<h4 class="font-medium text-blue-700 mb-2">出海主线</h4>
|
||
<p class="text-gray-600 text-sm">License-out占比高的公司（科伦博泰、石药集团）</p>
|
||
</div>
|
||
<div class="bg-white p-4 rounded-lg shadow-sm">
|
||
<h4 class="font-medium text-blue-700 mb-2">支付弹性</h4>
|
||
<p class="text-gray-600 text-sm">商保覆盖的罕见病药（如信达IBI311眼科）</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div>
|
||
<h3 class="text-xl font-semibold mb-3 text-gray-800">跟踪指标</h3>
|
||
<div class="bg-white p-4 rounded-lg shadow-sm">
|
||
<ul class="text-gray-700 space-y-2">
|
||
<li>• <span class="font-medium">2025年Q3</span>：丙类目录纳入品种数量（目标<span class="highlight">>50款</span>）</li>
|
||
<li>• <span class="font-medium">2025年ASCO</span>：中国ADC头对头数据（如恒瑞SHR-A1811 vs DS-8201）</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="mt-6 p-4 bg-gradient-to-r from-green-500 to-blue-500 rounded-xl text-white">
|
||
<h3 class="text-xl font-bold mb-2">一句话总结</h3>
|
||
<p class="text-lg">创新药正从"中国故事"走向"全球订单"，<span class="font-bold text-yellow-300">2025年是盈利与估值双击的起点</span></p>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- 关联股票表格 -->
|
||
<div class="section-card rounded-2xl p-6">
|
||
<h2 class="text-2xl font-bold text-gray-900 mb-6 flex items-center">
|
||
<i class="fas fa-table text-teal-500 mr-3"></i>关联股票数据
|
||
</h2>
|
||
<div class="table-container">
|
||
<table class="min-w-full bg-white rounded-lg overflow-hidden">
|
||
<thead class="bg-gray-100">
|
||
<tr>
|
||
<th class="px-4 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">股票名称</th>
|
||
<th class="px-4 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">行业</th>
|
||
<th class="px-4 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">项目</th>
|
||
<th class="px-4 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">分类</th>
|
||
</tr>
|
||
</thead>
|
||
<tbody class="divide-y divide-gray-200">
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">迈威生物</td>
|
||
<td class="px-4 py-3 text-sm">生物制品</td>
|
||
<td class="px-4 py-3 text-sm">重组蛋白</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">神州细胞</td>
|
||
<td class="px-4 py-3 text-sm">生物制品</td>
|
||
<td class="px-4 py-3 text-sm">重组蛋白</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">特宝生物</td>
|
||
<td class="px-4 py-3 text-sm">生物制品</td>
|
||
<td class="px-4 py-3 text-sm">重组蛋白</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">安科生物</td>
|
||
<td class="px-4 py-3 text-sm">生物制品</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">双鹭药业</td>
|
||
<td class="px-4 py-3 text-sm">生物制品</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">甘李药业</td>
|
||
<td class="px-4 py-3 text-sm">生物制品</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">减肥药</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">新诺威</td>
|
||
<td class="px-4 py-3 text-sm">原料药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">减肥药</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">博瑞医药</td>
|
||
<td class="px-4 py-3 text-sm">原料药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">键凯科技</td>
|
||
<td class="px-4 py-3 text-sm">原料药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">普洛药业</td>
|
||
<td class="px-4 py-3 text-sm">原料药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">减肥药</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">科伦药业</td>
|
||
<td class="px-4 py-3 text-sm">化学制剂</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">东诚药业</td>
|
||
<td class="px-4 py-3 text-sm">化学制剂</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">信立泰</td>
|
||
<td class="px-4 py-3 text-sm">化学制剂</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">减肥药</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">海思科</td>
|
||
<td class="px-4 py-3 text-sm">化学制剂</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">人福医药</td>
|
||
<td class="px-4 py-3 text-sm">化学制剂</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">百利天恒</td>
|
||
<td class="px-4 py-3 text-sm">化学制剂</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">上海谊众</td>
|
||
<td class="px-4 py-3 text-sm">化学制剂</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">红日药业</td>
|
||
<td class="px-4 py-3 text-sm">中药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">亚宝药业</td>
|
||
<td class="px-4 py-3 text-sm">中药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">方盛制药</td>
|
||
<td class="px-4 py-3 text-sm">中药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">新天药业</td>
|
||
<td class="px-4 py-3 text-sm">中药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">天士力</td>
|
||
<td class="px-4 py-3 text-sm">中药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">哈一药业</td>
|
||
<td class="px-4 py-3 text-sm">北交所</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">康乐卫士</td>
|
||
<td class="px-4 py-3 text-sm">北交所</td>
|
||
<td class="px-4 py-3 text-sm">重组蛋白</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">梓橦宫</td>
|
||
<td class="px-4 py-3 text-sm">北交所</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">生物谷</td>
|
||
<td class="px-4 py-3 text-sm">北交所</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">三元基因</td>
|
||
<td class="px-4 py-3 text-sm">北交所</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">普利制药</td>
|
||
<td class="px-4 py-3 text-sm">CRO</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">减肥药</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">昊帆生物</td>
|
||
<td class="px-4 py-3 text-sm">CRO</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">百诚医药</td>
|
||
<td class="px-4 py-3 text-sm">CRO</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">博腾股份</td>
|
||
<td class="px-4 py-3 text-sm">CRO</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">药明康德</td>
|
||
<td class="px-4 py-3 text-sm">CRO</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">美迪西</td>
|
||
<td class="px-4 py-3 text-sm">CRO</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">康龙化成</td>
|
||
<td class="px-4 py-3 text-sm">CRO</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">百普赛斯</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">重组蛋白</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">福瑞达</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">重组蛋白</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">丸美股份</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">重组蛋白</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">中源协和</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">重组蛋白</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">艾德生物</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">荣昌生物</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">迪哲医药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">贝达药业</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">常山药业</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">昆药集团</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">抗肿瘤药</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">一品红</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">千红制药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">吉贝尔</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">京新药业</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">新华制药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">肝炎</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">恒瑞医药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">减肥药</td>
|
||
</tr>
|
||
<tr>
|
||
<td class="px-4 py-3 font-medium">通化东宝</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">减肥药</td>
|
||
</tr>
|
||
<tr class="bg-gray-50">
|
||
<td class="px-4 py-3 font-medium">华森制药</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">-</td>
|
||
<td class="px-4 py-3 text-sm">减肥药</td>
|
||
</tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<script src="https://cdn.jsdelivr.net/npm/tsparticles@3/tsparticles.bundle.min.js"></script>
|
||
<script>
|
||
tsParticles.load("particles-js", {
|
||
particles: {
|
||
number: {
|
||
value: 80,
|
||
density: {
|
||
enable: true,
|
||
value_area: 800
|
||
}
|
||
},
|
||
color: {
|
||
value: "#3b82f6"
|
||
},
|
||
shape: {
|
||
type: "circle"
|
||
},
|
||
opacity: {
|
||
value: 0.5,
|
||
random: false
|
||
},
|
||
size: {
|
||
value: 3,
|
||
random: true
|
||
},
|
||
line_linked: {
|
||
enable: true,
|
||
distance: 150,
|
||
color: "#93c5fd",
|
||
opacity: 0.4,
|
||
width: 1
|
||
},
|
||
move: {
|
||
enable: true,
|
||
speed: 2,
|
||
direction: "none",
|
||
random: false,
|
||
straight: false,
|
||
out_mode: "out",
|
||
bounce: false
|
||
}
|
||
},
|
||
interactivity: {
|
||
detect_on: "canvas",
|
||
events: {
|
||
onhover: {
|
||
enable: true,
|
||
mode: "grab"
|
||
},
|
||
onclick: {
|
||
enable: true,
|
||
mode: "push"
|
||
},
|
||
resize: true
|
||
},
|
||
modes: {
|
||
grab: {
|
||
distance: 140,
|
||
line_linked: {
|
||
opacity: 1
|
||
}
|
||
},
|
||
push: {
|
||
particles_nb: 4
|
||
}
|
||
}
|
||
},
|
||
retina_detect: true
|
||
});
|
||
</script>
|
||
</body>
|
||
</html>
|
||
``` |